Cellular therapy (CT) is the transplantation of human cells to replace or repair damaged tissue and/or cells. With new technologies, innovative products, and limitless imagination, many different types of cells may be used as part of a therapy or treatment for a variety of diseases and conditions. Projected to expand at a CAGR of 6.3% from 2022 to 2028, the global cell therapy market will worth USD 10,481 million by 2028-end, According to the publisher.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global cell therapy market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the cell therapy industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the therapy type, product, application, end user, and region. The global market for cell therapy can be segmented by therapy type: allogeneic, autologous. Cell therapy market is further segmented by product: consumables, equipment, systems and software. Based on application, the cell therapy market is segmented into: cardiovascular, dermatology and wounds, malignancies, musculoskeletal disorders, others. On the basis of end user, the cell therapy market also can be divided into: research institutes, hospitals & clinics, others. Cell therapy market by region is categorized into: North America, Asia Pacific, Europe, Rest of the World (ROW).
By therapy type:
- allogeneic
- autologous
By product:
- consumables
- equipment
- systems and software
By application:
- cardiovascular
- dermatology and wounds
- malignancies
- musculoskeletal disorders
- others
By end user:
- research institutes
- hospitals & clinics
- others
By region:
- North America
- Asia Pacific
- Europe
- Rest of the World (ROW)
The global cell therapy market report offers detailed information on several market vendors, including Allogene Therapeutics, Inc., Castle Creek Biosciences, Inc., Cells for Cells S.A., Dendreon Pharmaceuticals, Inc., JCR Pharmaceuticals Co., Ltd., Juno Therapeutics Inc (Bristol Myers Squibb Co.), Kite Pharma, Inc. (Gilead Sciences, Inc.), Medipost Co., Ltd., Mesoblast Limited, Nipro Corporation, Novartis International AG, NuVasive, Inc., Organogenesis Holdings Inc., Smith & Nephew plc (Osiris Therapeutics, Inc.), Stemedica Cell Technologies, Inc., Stempeutics Research Pvt. Ltd., Takeda Pharmaceutical Company Limited, Vericel Corporation, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global cell therapy market.
- To classify and forecast the global cell therapy market based on therapy type, product, application, end user, region.
- To identify drivers and challenges for the global cell therapy market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global cell therapy market.
- To identify and analyze the profile of leading players operating in the global cell therapy market.
Why Choose This Report
- Gain a reliable outlook of the global cell therapy market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Interested in this report? Get your FREE sample!
Safe and Secure SSl Encryption
Licensing options
2200 USD
We offer 4 types of licenses
You can select one of these options upon checking out
Single User License (Electronic):
Allows one individual to access the purchased report
Hard Copy:
Allows up to five individuals to access the purchased report
Site License (Electronic):
Allows all employees of an organization to access the purchased report. Internal sharing only
Global User License (Electronic):
Allows all employees of an organization to access the purchased report. It also permits the use of up to 4 paragraphs or 1 page of the report externally in whitepapers, press releases, and marketing collateral
Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
We offer $1000 worth of FREE customization at the time of purchase
80% of the clinet request tailor made solution, how can we help you?
How client has rates us?
Requirement Gathering & Methodology
Data Collection Techniques
Our Research Team & Data Sourcing
Data Science & Analytical Tools
Data Visualization & Presentation Skills
Project/ Report Delivery & After Sales Services
Buy Chapters or Sections?
Avail customized purchase options to meet your exact research needs:
Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities
Cellular therapy (CT) is the transplantation of human cells to replace or repair damaged tissue and/or cells. With new technologies, innovative products, and limitless imagination, many different types of cells may be used as part of a therapy or treatment for a variety of diseases and conditions. Projected to expand at a CAGR of 6.3% from 2022 to 2028, the global cell therapy market will worth USD 10,481 million by 2028-end, According to the publisher. The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global cell therapy market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the cell therapy industry. This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the therapy type, product, application, end user, and region. The global market for cell therapy can be segmented by therapy type: allogeneic, autologous. Cell therapy market is further segmented by product: consumables, equipment, systems and software. Based on application, the cell therapy market is segmented into: cardiovascular, dermatology and wounds, malignancies, musculoskeletal disorders, others. On the basis of end user, the cell therapy market also can be divided into: research institutes, hospitals & clinics, others. Cell therapy market by region is categorized into: North America, Asia Pacific, Europe, Rest of the World (ROW). By therapy type: - allogeneic - autologous By product: - consumables - equipment - systems and software By application: - cardiovascular - dermatology and wounds - malignancies - musculoskeletal disorders - others By end user: - research institutes - hospitals & clinics - others By region: - North America - Asia Pacific - Europe - Rest of the World (ROW) The global cell therapy market report offers detailed information on several market vendors, including Allogene Therapeutics, Inc., Castle Creek Biosciences, Inc., Cells for Cells S.A., Dendreon Pharmaceuticals, Inc., JCR Pharmaceuticals Co., Ltd., Juno Therapeutics Inc (Bristol Myers Squibb Co.), Kite Pharma, Inc. (Gilead Sciences, Inc.), Medipost Co., Ltd., Mesoblast Limited, Nipro Corporation, Novartis International AG, NuVasive, Inc., Organogenesis Holdings Inc., Smith & Nephew plc (Osiris Therapeutics, Inc.), Stemedica Cell Technologies, Inc., Stempeutics Research Pvt. Ltd., Takeda Pharmaceutical Company Limited, Vericel Corporation, among others. *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES Historical & Forecast Period This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year. Scope of the Report - To analyze and forecast the market size of the global cell therapy market. - To classify and forecast the global cell therapy market based on therapy type, product, application, end user, region. - To identify drivers and challenges for the global cell therapy market. - To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global cell therapy market. - To identify and analyze the profile of leading players operating in the global cell therapy market. Why Choose This Report - Gain a reliable outlook of the global cell therapy market forecasts from 2022 to 2028 across scenarios. - Identify growth segments for investment. - Stay ahead of competitors through company profiles and market data. - The market estimate for ease of analysis across scenarios in Excel format. - Strategy consulting and research support for three months. - Print authentication provided for the single-user license.
Read More